ERYTHROPED

This brand name is authorized in Ireland, United Kingdom, South Africa

Active ingredients

The drug ERYTHROPED contains one active pharmaceutical ingredient (API):

1 Erythromycin UNII 1014KSJ86F - ERYTHROMYCIN ETHYLSUCCINATE

Erythromycin exerts its antimicrobial action by binding to the 50S ribosomal sub-unit of susceptible microorganisms and suppresses protein synthesis. Erythromycin is bacteriostatic and bactericidal depending on its concentration and the type of organism. Read about Erythromycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ERYTHROPED SF Granules	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FA01	Erythromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 142233, 161729, 196931, 19873, 19919, 24764, 24770
Country: IE	Health Products Regulatory Authority	Identifier(s): 23752, 91709, 91718, 91747
Country: ZA	Health Products Regulatory Authority	Identifier(s): R/20.1.1/143